血管性
医学
增殖指数
川地34
神经母细胞瘤
病理
基质
阶段(地层学)
胃肠病学
免疫组织化学
生物
古生物学
干细胞
遗传学
细胞培养
作者
Elżbieta Drożyńska,Ewa Iżycka‐Świeszewska,Maciej Niedźwiecki,Anna Balcerska,Danuta Perek,Jacek Wachowiak
出处
期刊:Neoplasma
[AEPress, s.r.o.]
日期:2006-01-01
卷期号:53 (3): 247-252
被引量:2
摘要
Seventy-four neuroblastoma patients were analyzed according to the clinical data including age, stage, bone metastases, primary tumor localization, tumor diameter, LDH, and serum ferritin. Histological examination of tumor specimens comprised calculation of proliferative index (PI) on slides stained with anti Ki-67 antibody and assessment of microvascular density (MVD) on anti-CD34 stained sections. Wide range of PI (1.5-79; median 37.8%) and MVD (41-385; median 172/mm2) values was observed. Significant relationship between higher PI and tumor diameter more than 5 cm (40.3 vs 37.2%) was found. Lower PI was found more frequently in stroma-rich tumors. Significantly higher median MVD was found in infant tumors and in smaller tumors 1-year old. We evaluated the new parameter: proliferative-vascular index (PVI) as PVI=PIxMVD which ranged from 213-18333. Among eleven patients >1 year old, with PVI >7000, seven (64%) had a poor outcome within the mean period of 22 months. Our results suggest that the simultaneous estimation of proliferative activity and vascularity of neuroblastomas could be studied as a prognostic indicator. Further investigations are needed to confirm this finding.
科研通智能强力驱动
Strongly Powered by AbleSci AI